GE HealthCare Technologies Inc. Common Stock
Here’s whether GE HealthCare Technologies Inc. Common Stock (GEHC) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.
Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-2.29% over 10 days); RSI 71 — overbought, elevated pullback risk; 3-month momentum negative (-14.5%). Currently 28.0% off its 52-week high. Score: -6/7.
GEHC is trading below its 200-day MA ($75.09) — a key warning sign the longer-term trend is under pressure. With an RSI of 71.0, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of -9.6% compares to +24.4% for SPY (trailed the market by 34.0%). The current 28.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.